1555 Results for
- View:
- Only Recruiting Trials
-
All Trials
| Study Title | Principal Investigator |
|---|---|
|
A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Variable Treatment Duration Study Evaluating the Efficacy and Safety of Siponimod (BAF312) in Patients With Secondary Progressive Multiple Sclerosis.
Completed | Multiple Sclerosis | Multisite
|
|
Powered by
SC CTSI